fosamprenavir has been researched along with warfarin in 2 studies
| Studies (fosamprenavir) | Trials (fosamprenavir) | Recent Studies (post-2010) (fosamprenavir) | Studies (warfarin) | Trials (warfarin) | Recent Studies (post-2010) (warfarin) |
|---|---|---|---|---|---|
| 174 | 55 | 37 | 36,573 | 2,143 | 14,728 |
| Protein | Taxonomy | fosamprenavir (IC50) | warfarin (IC50) |
|---|---|---|---|
| Vitamin K epoxide reductase complex subunit 1 | Homo sapiens (human) | 0.0088 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gatanaga, H; Goto, K; Honda, H; Honda, M; Kamimura, M; Kikuchi, Y; Matsumura, J; Oka, S; Teruya, K; Tsukada, K | 1 |
1 review(s) available for fosamprenavir and warfarin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for fosamprenavir and warfarin
| Article | Year |
|---|---|
Favourable use of non-boosted fosamprenavir in patients treated with warfarin.
Topics: Adult; Anti-HIV Agents; Anticoagulants; Atrial Fibrillation; Carbamates; Drug Interactions; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Japan; Male; Middle Aged; Organophosphates; Sulfonamides; Treatment Outcome; Warfarin | 2009 |